Ocugen, Inc. (OCGN)
NASDAQ: OCGN · IEX Real-Time Price · USD
1.640
-0.140 (-7.87%)
At close: Mar 28, 2024, 4:00 PM
1.650
+0.010 (0.61%)
After-hours: Mar 28, 2024, 7:59 PM EDT
Ocugen Market Cap
Ocugen has a market cap or net worth of $446.31 million as of March 28, 2024. Its market cap has increased by 106.82% in one year.
Market Cap
446.31M
Enterprise Value
399.31M
1-Year Change
106.82%
Ranking
Category
Stock Price
$1.64
Market Cap Chart
Since December 3, 2014, Ocugen's market cap has increased from $126.80M to $446.31M, an increase of 251.98%. That is a compound annual growth rate of 14.46%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 456.60M | 2.91% |
Mar 26, 2024 | 443.70M | -5.48% |
Mar 25, 2024 | 469.40M | 11.58% |
Mar 22, 2024 | 420.70M | 22.40% |
Mar 21, 2024 | 343.70M | 8.05% |
Mar 20, 2024 | 318.10M | 12.72% |
Mar 19, 2024 | 282.20M | 6.81% |
Mar 18, 2024 | 264.20M | -4.62% |
Mar 15, 2024 | 277.00M | 5.89% |
Mar 14, 2024 | 261.60M | -1.95% |
Mar 13, 2024 | 266.80M | 5.71% |
Mar 12, 2024 | 252.40M | 4.47% |
Mar 11, 2024 | 241.60M | -4.66% |
Mar 8, 2024 | 253.40M | -2.20% |
Mar 7, 2024 | 259.10M | 16.08% |
Mar 6, 2024 | 223.20M | 0.81% |
Mar 5, 2024 | 221.40M | -1.91% |
Mar 4, 2024 | 225.70M | -8.33% |
Mar 1, 2024 | 246.20M | 2.54% |
Feb 29, 2024 | 240.10M | -0.54% |
Feb 28, 2024 | 241.40M | -4.92% |
Feb 27, 2024 | 253.90M | 9.96% |
Feb 26, 2024 | 230.90M | 13.35% |
Feb 23, 2024 | 203.70M | -20.34% |
Feb 22, 2024 | 255.70M | -5.96% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
PetIQ | 511.81M |
Phibro Animal Health | 508.32M |
Orthofix Medical | 507.23M |
CareDx | 503.29M |
Voyager Therapeutics | 502.82M |
Nevro | 500.11M |
SNDL Inc. | 497.23M |
Larimar Therapeutics | 495.09M |